Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacira Pharmaceuticals

24.87
-0.5500-2.16%
Post-market: 24.870.00000.00%16:07 EDT
Volume:543.61K
Turnover:13.60M
Market Cap:1.15B
PE:-10.96
High:25.66
Open:25.51
Low:24.76
Close:25.42
Loading ...

Pacira Announces Updates to Board of Directors

GlobeNewswire
·
30 Jan

Pacira Biosciences Inc : Truist Securities Raises Target Price to $25 From $8

THOMSON REUTERS
·
30 Jan

Truist Upgrades Pacira Biosciences to Hold From Sell, Boosts Price Target to $25 From $8

MT Newswires Live
·
30 Jan

Pacira upgraded to Hold from Sell at Truist

TIPRANKS
·
30 Jan

Barclays Reaffirms Their Hold Rating on Pacira Pharmaceuticals (PCRX)

TIPRANKS
·
27 Jan

BRIEF-Pacira Biosciences Strengthens Executive Leadership Team

Reuters
·
21 Jan

Pacira appoints Teehan as CCO, Corbett as CBO

TIPRANKS
·
21 Jan

Pacira Biosciences Strengthens Executive Leadership Team With Two Key Appointments

THOMSON REUTERS
·
21 Jan

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks
·
17 Jan

Pacira BioSciences Price Target Maintained With a $18.00/Share by RBC Capital

Dow Jones
·
15 Jan

Shareholders that lost money on Pacira BioSciences, Inc.(PCRX) should contact Levi & Korsinsky LLP about pending Class Action – PCRX

TIPRANKS
·
14 Jan

PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales

Zacks
·
14 Jan

Pacira Biosciences Inc : Needham Raises Target Price to $30 From $22

THOMSON REUTERS
·
13 Jan

Pacira Biosciences Reports Preliminary 2024 Revenue Rose, Outlines Five-Year Plan

MT Newswires Live
·
10 Jan

BRIEF-Pacira Biosciences Sees Double-Digit Compounded Annual Growth Rate In Product Revenue By 2030

Reuters
·
10 Jan

Pacira Biosciences: Prelim Q4 Exparel Net Product Sales of $147.7 Mln

THOMSON REUTERS
·
10 Jan

Pacira Biosciences Inc: Sees 5 Pct Point Gross Margin Improvement Over 2024 in Profitability by 2030

THOMSON REUTERS
·
10 Jan

Pacira Biosciences: Sees Double-Digit Compounded Annual Growth Rate in Product Revenue by 2030

THOMSON REUTERS
·
10 Jan

FDA Clears PCRX's New Iovera Smart Tip for Expanded Use in Pain Relief

Zacks
·
09 Jan

Pacira BioSciences Secures FDA Approval For New iovera SmartTip to Manage Chronic Low Back Pain

Benzinga
·
08 Jan